List of bibliographic references
Number of relevant bibliographic references: 11.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 7 | Humans |
| 6 | Female |
| 5 | HIV-1 (genetics) |
| 4 | Adult |
| 4 | HIV Infections (virology) |
| 4 | HIV-1 (immunology) |
| 3 | Disease Progression |
| 3 | HIV Infections (immunology) |
| 3 | HIV Infections (prevention & control) |
| 3 | South Africa (epidemiology) |
| 3 | Young Adult |
| 2 | Anti-Infective Agents (administration & dosage) |
| 2 | HIV Infections (blood) |
| 2 | HIV Infections (epidemiology) |
| 2 | HIV Infections (transmission) |
| 2 | Middle Aged |
| 2 | Sequence Analysis, DNA |
| 2 | gag Gene Products, Human Immunodeficiency Virus (genetics) |
| 1 | Acci |
| 1 | African samples |
| 1 | Alamos database |
| 1 | Algorithms |
| 1 | Alui |
| 1 | Alui digestion |
| 1 | Amino Acid Sequence |
| 1 | Anti-HIV Agents (administration & dosage) |
| 1 | Anti-HIV Agents (pharmacology) |
| 1 | Anti-HIV Agents (therapeutic use) |
| 1 | Anti-Infective Agents (pharmacology) |
| 1 | Anti-Infective Agents (therapeutic use) |
| 1 | Antibodies, Monoclonal (immunology) |
| 1 | Antibodies, Monoclonal (isolation & purification) |
| 1 | Antibodies, Monoclonal (ultrastructure) |
| 1 | Antibodies, Neutralizing (immunology) |
| 1 | Antibodies, Neutralizing (isolation & purification) |
| 1 | Antigens, CD4 (pharmacology) |
| 1 | Binding Sites, Antibody (genetics) |
| 1 | Binding Sites, Antibody (immunology) |
| 1 | Biomarkers (blood) |
| 1 | Boehringer mannheim |
| 1 | CD4 Lymphocyte Count |
| 1 | Cape town |
| 1 | Cell Line, Tumor |
| 1 | Clinical Trials as Topic |
| 1 | Cohort Studies |
| 1 | Common subtype |
| 1 | Complementarity Determining Regions (genetics) |
| 1 | Consensus sequences |
| 1 | Crystallography, X-Ray |
| 1 | Cytokines (blood) |
| 1 | Cytokines (immunology) |
| 1 | Democratic republic |
| 1 | Digestion |
| 1 | Disease Transmission, Infectious (prevention & control) |
| 1 | Elsevier science |
| 1 | Endonuclease |
| 1 | Epitopes |
| 1 | Epitopes (immunology) |
| 1 | European workshop report |
| 1 | Evolution, Molecular |
| 1 | Follow-Up Studies |
| 1 | Fragment |
| 1 | Fragment sizes |
| 1 | Genetic diversity |
| 1 | Genome, Viral |
| 1 | Glycosylation |
| 1 | HIV Antibodies (immunology) |
| 1 | HIV Antibodies (isolation & purification) |
| 1 | HIV Antigens (genetics) |
| 1 | HIV Antigens (immunology) |
| 1 | HIV Antigens (ultrastructure) |
| 1 | HIV Envelope Protein gp120 (genetics) |
| 1 | HIV Envelope Protein gp120 (immunology) |
| 1 | HIV Envelope Protein gp41 (genetics) |
| 1 | HIV Envelope Protein gp41 (immunology) |
| 1 | HIV Infections (diagnosis) |
| 1 | HIV Infections (drug therapy) |
| 1 | HIV Infections (pathology) |
| 1 | HIV-1 (drug effects) |
| 1 | HIV-1 (isolation & purification) |
| 1 | HIV-1 (physiology) |
| 1 | Harmelen |
| 1 | HeLa Cells |
| 1 | Heteroduplex mobility assay |
| 1 | Heterosexual infections |
| 1 | Heterosexual population |
| 1 | Host-Pathogen Interactions |
| 1 | Human immunodeficiency virus type-1 (HIV-1) |
| 1 | Human lymphotrophic virus type |
| 1 | Human virus type |
| 1 | Immune Evasion (genetics) |
| 1 | Immune Evasion (immunology) |
| 1 | India (epidemiology) |
| 1 | Infectious bursal disease virus |
| 1 | Inner primers |
| 1 | Inner reactions |
| 1 | Leukocytes, Mononuclear (virology) |
| 1 | Limited diversity |
| 1 | Longitudinal Studies |
| 1 | Male |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Carolyn Williamson"
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i \
-Sk "Carolyn Williamson" \
| HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= RSA
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Carolyn Williamson
}}
| This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024 |  |
